Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Thiotepa and busulfan combined with cyclophosphamide conditioning regimen plus maintenance therapy improved the disease-free survival of patients with relapsed/refractory haematologic malignancies after undergoing allogeneic transplantation

Shulian Chen, Rui Cui, Yi He, Qiaoling Ma, Rongli Zhang, Xin Chen, Wenbin Cao, Jialin Wei, Donglin Yang, Aiming Pang, Sizhou Feng, Mingzhe Han, Weihua Zhai, Erlie Jiang

Blood (2025) 146 (Supplement 1): 5974.

https://doi.org/10.1182/blood-2025-5974

Published: 2025

Journal Articles

Olverembatinib-mediated deep remission improves allogeneic stem cell transplantation outcome in patients with blast crisis chronic myeloid leukemia: First real-world practice report

Xiaoyu Zhang, Bingcheng LIU, Weihua Zhai, Qiaoling MA, Donglin Yang, Aiming Pang, Sizhou Feng, Mingzhe Han, Yi He, Hui Wei, Erlie Jiang

Blood (2025) 146 (Supplement 1): 1999.

https://doi.org/10.1182/blood-2025-1999

Published: 2025

Journal Articles

Comparison of different dose of anti-T lymphocyte globulin (ATLG) in haploidentical HSCT for gvhd prophylaxis

Blood (2025) 146 (Supplement 1): 2468.

https://doi.org/10.1182/blood-2025-2468

Published: 2025

Journal Articles

Early allogeneic stem cell transplantation enhanced survival of co-expressed NUP98::NSD1 and FLT3-ITD Acute Myeloid Leukemia: An exploratory analysis.

Runzhi Ma, Xiaoyu Zhang, Xiaoli Zhao, Qiaoling MA, Weihua Zhai, Donglin Yang, Aiming Pang, Sizhou Feng, Mingzhe Han, Yi He, Erlie Jiang

Blood (2025) 146 (Supplement 1): 7805.

https://doi.org/10.1182/blood-2025-7805

Published: 2025

Journal Articles

Autologous hematopoietic stem cell transplantation combined with inaticabtagene autoleucel in adults with high-risk B-cell acute lymphoblastic leukemia: Interim analysis of a phase II study

Erlie Jiang, Rongli Zhang, Aiming Pang, Donglin Yang, Yi He, Jialin Wei, Yigeng Cao, Xin Chen, Wenbin Cao, Chen Liang, Qiaoling MA, Weihua Zhai, Qingzhen Liu, Tingting Zhang, Yuanyuan Shi, Xiaofei Ni, Mengnan LV, Jiali wang, Fengjiao Wang

Blood (2025) 146 (Supplement 1): 5929.

https://doi.org/10.1182/blood-2025-5929

Published: 2025

Journal Articles

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Wang Ying, Jianxiang Wang, Weihua Zhai, Erlie Jiang

Blood (2024) 144 (Supplement 1): 6054.

https://doi.org/10.1182/blood-2024-202404

Published: 2024

Journal Articles

The Comparison between Chimeric Mouse-Human and Humanized Anti-CD25 Monoclonal Antibody for Steroid-Refractory Acute Graft-Versus-Host Disease

Xinhui Zheng, Xin Chen, Yawei Zheng, Weihua Zhai, Donglin Yang, Jialin Wei, Aiming Pang, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 2144.

https://doi.org/10.1182/blood-2024-207001

Published: 2024

Journal Articles

Outcomes of Hematopoietic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for B-Cell Acute Lymphoblastic Leukemia without VOD/SOS

Erlie Jiang, Mengnan Lv, Weihua Zhai

Blood (2024) 144 (Supplement 1): 5855.

https://doi.org/10.1182/blood-2024-204523

Published: 2024

Journal Articles

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

Dewan Zhao, Wenbin Cao, Gang Li, Ying Zhang, Xiaohui Zheng, Xin Chen, Weihua Zhai, Qiaoling MA, Rongli Zhang, Jialin Wei, Aiming Pang, Yi He, Donglin Yang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7432.

https://doi.org/10.1182/blood-2024-205145

Published: 2024

Journal Articles

Humanized Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis in Older Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation

Xiaoyu Zhang, Weihua Zhai, Qiaoling MA, Sizhou Feng, Yi He, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7366.

https://doi.org/10.1182/blood-2024-207353

Published: 2024

Journal Articles

The Efficacy and Safety of the Addition of Mitoxantrone Hydrochloride Liposome in Conditioning Regimen for High-Risk Acute Myeloid Leukemia: The Short-TERM Analysis

Xiaoyu Zhang, Weihua Zhai, Qiaoling MA, Mingzhe Han, Sizhou Feng, Yi He, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7318.

https://doi.org/10.1182/blood-2024-207762

Published: 2024

Journal Articles

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Xiaoyu Zhang, Yanhong Zhao, Rongli Zhang, Weihua Zhai, Yi He, Jialin Wei, Donglin Yang, Aiming Pang, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5892.

https://doi.org/10.1182/blood-2023-184400

Published: 2023

Journal Articles

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

Yanhong Zhao, Weihua Zhai, Aiming Pang, Donglin Yang, Yi He, Jialin Wei, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5893.

https://doi.org/10.1182/blood-2023-184565

Published: 2023

Journal Articles

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Weihua Zhai, Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Ying Wang, Erlie Jiang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 7073.

https://doi.org/10.1182/blood-2023-180077

Published: 2023

Journal Articles

The Modified Melphalan-Cladribine-Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo-HSCT in Refractory/Relapsed AML

Xiaoyu Zhang, Shulian Chen, Weihua Zhai, Yi He, Sizhou Feng, Mingzhe Han, Ting Niu, Yajing Xu, Guangxun Gao, Shengjin Fan, Zepin Zhou, Fang Zhou, Rui Xi, Li Liu, Wei Yang, Xi Zhang, Qifa Liu, Erlie Jiang

Blood (2023) 142 (Supplement 1): 474.

https://doi.org/10.1182/blood-2023-184477

Published: 2023

Journal Articles

Ceftazidime-Avibactam in the Treatment of Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacteria in Hematological Patients: Experience in a Single Center

Sisi Zhen, Qingsong Lin, Weihua Zhai, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5363.

https://doi.org/10.1182/blood-2023-188815

Published: 2023

Journal Articles

Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS

Yigeng Cao, Wenwen Guo, Weihua Zhai, Jialin Wei, Qiaoling MA, Donglin Yang, AiMing Pang, Mingzhe Han, Erlie Jiang

Blood (2023) 142 (Supplement 1): 4952.

https://doi.org/10.1182/blood-2023-180847

Published: 2023

Journal Articles

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

Mengnan Lv, Yi He, Donglin Yang, Qiaoling MA, Aiming Pang, Weihua Zhai, Jialin Wei, Xin Chen, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5900.

https://doi.org/10.1182/blood-2023-188534

Published: 2023

Journal Articles

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

Xiaoyu Zhang, Donglin Yang, Aiming Pang, Yi He, Jialin Wei, Rongli Zhang, Weihua Zhai, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 7027.

https://doi.org/10.1182/blood-2023-182816

Published: 2023

Journal Articles

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Xiaofei Ni, Weihua Zhai, AiMing Pang, Donglin Yang, Xin Chen, Qiaoling MA, Jialin Wei, Yi He, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 6974.

https://doi.org/10.1182/blood-2023-181449

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Thiotepa and busulfan combined with cyclophosphamide conditioning regimen plus maintenance therapy improved the disease-free survival of patients with relapsed/refractory haematologic malignancies after undergoing allogeneic transplantation

Olverembatinib-mediated deep remission improves allogeneic stem cell transplantation outcome in patients with blast crisis chronic myeloid leukemia: First real-world practice report

Comparison of different dose of anti-T lymphocyte globulin (ATLG) in haploidentical HSCT for gvhd prophylaxis

Early allogeneic stem cell transplantation enhanced survival of co-expressed NUP98::NSD1 and FLT3-ITD Acute Myeloid Leukemia: An exploratory analysis.

Autologous hematopoietic stem cell transplantation combined with inaticabtagene autoleucel in adults with high-risk B-cell acute lymphoblastic leukemia: Interim analysis of a phase II study

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

The Comparison between Chimeric Mouse-Human and Humanized Anti-CD25 Monoclonal Antibody for Steroid-Refractory Acute Graft-Versus-Host Disease

Outcomes of Hematopoietic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for B-Cell Acute Lymphoblastic Leukemia without VOD/SOS

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

Humanized Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis in Older Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation

The Efficacy and Safety of the Addition of Mitoxantrone Hydrochloride Liposome in Conditioning Regimen for High-Risk Acute Myeloid Leukemia: The Short-TERM Analysis

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

The Modified Melphalan-Cladribine-Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo-HSCT in Refractory/Relapsed AML

Ceftazidime-Avibactam in the Treatment of Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacteria in Hematological Patients: Experience in a Single Center

Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only